Related Experiment Video
Updated: Feb 8, 2026

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
Perceptions and attitudes toward clinical trials in adolescent and young adults with cancer: a systematic review
Victoria Forcina1, Branavan Vakeesan1, Chelsea Paulo1
1Adolescent and Young Adult Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Purpose:
Although cancer clinical trials (CT) offer opportunities for novel treatments that may lead to improved outcomes, adolescents and young adults (AYA) are less likely to participate in these trials as compared to younger children and older adults. We aimed to identify the perceptions and attitudes toward CT in AYA that influence trial participation.
Materials And Methods:
A systematic review of cancer literature was conducted that assessed perceptions and attitudes toward CT enrollment limited to AYA patients (defined as age 15-39). We estimated the frequency of identified themes by pooling identified studies.
Results:
In total, six original research articles were identified that specifically addressed perceptions or attitudes that influenced CT participation in AYA patients. Three studies were conducted at pediatric centers - one at an AYA unit, one at an adult cancer hospital, and one was registry based. Major themes identified for CT acceptability included: hope for positive clinical affect, altruism, and having autonomy. Potential deterrents included: prolonged hospitalization, worry of side effects, and discomfort with experimentation.
Conclusion:
Limited information is available with regard to the perceptions and attitudes toward CT acceptability among AYA patients, especially those treated at adult cancer centers, which prevents generalization of data and themes. Future research assessing strategies for understanding and supporting CT decision-making processes among AYA represents a key focus for future funding to improve CT enrollment.
Insights
Adolescents and young adults (AYA) show interest in cancer clinical trials (CT) due to hope and autonomy, but are deterred by hospitalization and side effect fears. Understanding these factors is key to improving AYA participation in cancer research.
Area of Science:
- Oncology
- Clinical Research
- Adolescent and Young Adult Medicine
Background:
- Adolescents and young adults (AYA) have lower participation rates in cancer clinical trials (CT) compared to other age groups.
- Understanding AYA perceptions is crucial for improving enrollment in novel cancer treatments.
Purpose of the Study:
- To identify perceptions and attitudes influencing cancer clinical trial participation among adolescents and young adults (AYA).
Main Methods:
- Systematic review of six original research articles on AYA perceptions of CT enrollment (ages 15-39).
- Analysis of themes related to CT acceptability and deterrents across studies from pediatric and adult cancer centers.
Main Results:
- Key themes for CT acceptability in AYA include hope for positive outcomes, altruism, and desire for autonomy.
- Deterrents to CT participation for AYA involve concerns about prolonged hospitalization, side effects, and experimental aspects.
Conclusions:
- Limited data exists on AYA perceptions of CT, especially from adult cancer centers, hindering generalizability.
- Future research should focus on strategies to support AYA decision-making to enhance CT enrollment.
Related Concept Videos
Attitudes
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Revisionist Views of Adolescent and Adult Cognition
Statistical Software for Data Analysis and Clinical Trials
Review and Preview
Percentiles are a type of fractile that partition data into...

